Toxoplasma gondii inhibits R5 HIV-1 replication in human lymphoid tissues ex vivo

Microbes and Infection

Volumn 11, Issue 14-15, 2009, Pages 1106-1113

  Sassi, Atfa ^a   Brichacek, Beda ^a   Hieny, Sara ^b   Yarovinsky, Felix ^c   Golding, Hana ^d   Grivel, Jean Charles ^a   Sher, Alan ^b   Margolis, Leonid ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Cyclophilin; Ex vivo; HIV; Human lymphoid tissue; Toxoplasma gondii

Indexed keywords

CYCLOPHILIN; CYCLOPHILIN 18; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; MIXED INFECTION; PRIORITY JOURNAL; TONSIL; TOXOPLASMA GONDII; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; CYCLOPHILINS; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOID TISSUE; PALATINE TONSIL; PROTOZOAN PROTEINS; RECEPTORS, CCR5; RECOMBINANT PROTEINS; TOXOPLASMA; TOXOPLASMOSIS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; TOXOPLASMA GONDII;

EID: 71649113049     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2009.08.004     Document Type: Article

References (30)

1. Casoli C., Vicenzi E., Cimarelli A., Magnani G., Ciancianaini P., Cattaneo E., Dall'Aglio P., Poli G., and Bertazzoni U. HTLV-II down-regulates HIV-1 replication in IL-2-stimulated primary PBMC of coinfected individuals through expression of MIP-1alpha. Blood 95 (2000) 2760-2769
2. Goyal S., Kannangai R., Abraham A.M., Ebenezer D.L., and Sridharan G. Lack of increased frequency of human immunodeficiency virus infection in individuals with dengue-like illness in South India. Indian J. Med. Microbiol. 25 (2007) 300-301
3. Grivel J.C., Ito Y., Faga G., Santoro F., Shaheen F., Malnati M.S., Fitzgerald W., Lusso P., and Margolis L. Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6. Nat. Med. 7 (2001) 1232-1235
4. Lisco A., Grivel J.C., Biancotto A., Vanpouille C., Origgi F., Malnati M.S., Schols D., Lusso P., and Margolis L.B. Viral interactions in human lymphoid tissue: human herpesvirus 7 suppresses the replication of CCR5-tropic human immunodeficiency virus type 1 via CD4 modulation. J. Virol. 81 (2007) 708-717
5. Moss W.J., Ryon J.J., Monze M., Cutts F., Quinn T.C., and Griffin D.E. Suppression of human immunodeficiency virus replication during acute measles. J. Infect. Dis. 185 (2002) 1035-1042
6. Vanpouille C., Biancotto A., Lisco A., and Brichacek B. Interactions between human immunodeficiency virus type 1 and vaccinia virus in human lymphoid tissue ex vivo. J. Virol. 81 (2007) 12458-12464
7. Watt G., Kantipong P., de Souza M., Chanbancherd P., Jongsakul K., Ruangweerayud R., Loomis-Price L.D., Polonis V., Myint K.S., Birx D.L., Brown A.E., and Krishna S. HIV-1 suppression during acute scrub-typhus infection. Lancet 356 (2000) 475-479
8. Xiang J., Wunschmann S., Diekema D.J., Klinzman D., Patrick K.D., George S.L., and Stapleton J.T. Effect of coinfection with GB virus C on survival among patients with HIV infection. N. Engl. J. Med. 345 (2001) 707-714
9. Lusso P., and Gallo R.C. Human herpesvirus 6 in AIDS. Immunol. Today 16 (1995) 67-71
10. Berger E.A., Murphy P.M., and Farber J.M. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism and disease. Annu. Rev. Immunol. 17 (1999) 657-700
11. Grivel J.C., Garcia M., Moss W., and Margolis L. Measles virus inhibits HIV-1 replication in human lymphoid tisue ex vivo. J. Inf. Dis. 196 (2007) 541-549
12. Margolis L. Cytokines-strategic weapons in germ warfare?. Nat. Biotechnol. 21 (2003) 15-16
13. Hauser W.E., Luft B.J., Conley F.K., and Remington J.S. Central-nervous-system toxoplasmosis in homosexual and heterosexual adults. N. Engl. J. Med. 307 (1982) 498-499
14. Luft B.J., Conley F., Remington J.S., Laverdiere M., Wagner K.F., Levine J.F., Craven P.C., Strandberg D.A., File T.M., Rice N., and Meunier-Carpentier F. Outbreak of central-nervous-system toxoplasmosis in western Europe and North America. Lancet 1 (1983) 781-784
15. Luft B.J., and Remington J.S. Toxoplasmic encephalitis in AIDS. Clin. Infect. Dis. 15 (1992) 211-222
16. Jones J.L., Hanson D.L., Dworkin M.S., Kaplan J.E., and Ward J.W. Trends in AIDS-related opportunistic infections among men who have sex with men and among injecting drug users, 1991-1996. J. Infect. Dis. 178 (1998) 114-120
17. Palella Jr. F.J., Delaney K.M., Moorman A.C., Loveless M.O., Fuhrer J., Satten G.A., Aschman D.J., and Holmberg S.D. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV outpatient study investigators. N. Engl. J. Med. 338 (1998) 853-860
18. Bala S., Englund G., Kovacs J., Wahl L., Martin M., Sher A., and Gazzinelli R.T. Toxoplasma gondii soluble products induce cytokine secretion by macrophages and potentiate in vitro replication of a monotropic strain of HIV. J. Eukaryot. Microbiol. 41 (1994) 7S
19. Gazzinelli R.T., Ropert C., and Campos M.A. Role of the Toll/interleukin-1 receptor signaling pathway in host resistance and pathogenesis during infection with protozoan parasites. Immunol. Rev. 201 (2004) 9-25
20. Aliberti J., Valenzuela J.G., Carruthers V.B., Hieny S., Andersen J., Charest H., Reis e Sousa C., Fairlamb A., Ribeiro J.M., and Sher A. Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nat. Immunol. 4 (2003) 485-490
21. Golding H., Khurana S., Yarovinsky F., King L.R., Abdoulaeva G., Antonsson L., Owman C., Platt E.J., Kabat D., Andersen J.F., and Sher A. CCR5N-terminal region plays a critical role in HIV-1 inhibition by Toxoplasma gondii-derived cyclophilin-18. J. Biol. Chem. 280 (2005) 29570-29577
22. Yarovinsky F., Andersen J.F., King L.R., Caspar P., Aliberti J., Golding H., and Sher A. Structural determinants of the anti-HIV activity of a CCR5antagonist derived from Toxoplasma gondii. J. Biol. Chem. 279 (2004) 53635-53642
23. Ito Y., Grivel J.C., Chen S., Kiselyeva Y., Reichelderfer P., and Margolis L. CXCR4-tropic HIV-1 suppresses replication of CCR5-tropic HIV-1 in human lymphoid tissue by selective induction of CC-chemokines. J. Infect. Dis. 189 (2004) 506-514
24. Golding H., Aliberti J., King L.R., Manischewitz J., Andersen J., Valenzuela J., Landau N.R., and Sher A. Inhibition of HIV-1 infection by a CCR-5 binding cyclophilin from Toxoplasma gondii. Blood (2003)
25. Whitcomb E.A., Dinarello C.A., and Pincus S.H. Differential effects of interleukin-1 alpha and interleukin-1 beta on human peripheral blood eosinophils. Blood 73 (1989) 1904-1908
26. Xiang J., George S.L., Wunschmann S., Chang Q., Klinzman D., and Stapleton J.T. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. Lancet 363 (2004) 2040-2046
27. Osborn L., Kunkel S., and Nabel G.J. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc. Natl. Acad. Sci. U. S. A. 86 (1989) 2336-2340
28. von Briesen H., von Mallinckrodt C., Esser R., Muller S., Becker K., Rubsamen-Waigmann H., and Andreesen R. Effect of cytokines and lipopolysaccharides on HIV infection of human macrophages. Res. Virol. 142 (1991) 197-204
29. Bisson G.P., Strom B.L., Gross R., Weissman D., Klinzman D., Hwang W.T., Kostman J.R., Metzger D., Stapleton J.T., and Frank I. Effect of GB virus C viremia on HIV acquisition and HIV set-point. AIDS 19 (2005) 1910-1912
30. Stapleton J.T., Xiang J., and Williams C.F. HIV and GB virus C coinfection. Lancet Infect. Dis. 6 (2006) 187-188 author reply 188-9